Levodopa for the treatment of Parkinson's disease

N Engl J Med. 2008 Dec 4;359(23):2468-76. doi: 10.1056/NEJMct0800326.
No abstract available

Publication types

  • Review

MeSH terms

  • Antiparkinson Agents / adverse effects
  • Antiparkinson Agents / therapeutic use*
  • Brain / metabolism
  • Brain Stem / pathology
  • Dopamine / biosynthesis*
  • Humans
  • Levodopa / adverse effects
  • Levodopa / metabolism
  • Levodopa / therapeutic use*
  • Male
  • Middle Aged
  • Neurons / metabolism
  • Parkinson Disease / drug therapy*
  • Parkinson Disease / metabolism
  • Parkinson Disease / pathology
  • Practice Guidelines as Topic

Substances

  • Antiparkinson Agents
  • Levodopa
  • Dopamine